Advanced Solid Cancer: Clinical Trials

2 trials for Advanced Solid Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 1, Recruiting 1
Phase 22Active not recruiting 1, Recruiting 1

Follow Advanced Solid Cancer: new trials by email Literature Review of Advanced Solid Cancer trials Research Report on Advanced Solid Cancer

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of MHB046C Injection in Patients With Advanced Solid Tumors
MHB046C - Advanced Solid Cancer
Phase 1 / Phase 2RecruitingMinghui Pharmaceutical (Hangzhou) Ltd2002025-07-172026-10-09
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
ARV-806 - KRAS G12D Mutation, Advanced Solid Cancer
Phase 1 / Phase 2Active not recruitingArvinas Inc.762025-05-292026-09-16

Narrower conditions

Adenocarcinoma Of Esophagus (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Cholangiocarcinoma (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Endometrial Neoplasms (1)  ·  Gallbladder Neoplasms (1)  ·  Melanoma (1)  ·  Ovarian Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Stomach Neoplasms (1)  ·  Thyroid Neoplasms (1)

Broader conditions

Adenocarcinoma (1)  ·  Adnexal Diseases (1)  ·  Biliary Tract Diseases (1)  ·  Biliary Tract Neoplasms (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma (1)  ·  Carcinoma, Bronchogenic (1)  ·  Colonic Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Gallbladder Diseases (1)

Sponsors

Arvinas Inc. (1)  ·  Minghui Pharmaceutical (Hangzhou) Ltd (1)

Countries

China (1)  ·  United States (1)

NIH funding

2025 (1)